R.R. Barakat

3.7k total citations · 1 hit paper
60 papers, 2.8k citations indexed

About

R.R. Barakat is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, R.R. Barakat has authored 60 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Reproductive Medicine, 26 papers in Obstetrics and Gynecology and 17 papers in Surgery. Recurrent topics in R.R. Barakat's work include Ovarian cancer diagnosis and treatment (35 papers), Endometrial and Cervical Cancer Treatments (26 papers) and Intraperitoneal and Appendiceal Malignancies (11 papers). R.R. Barakat is often cited by papers focused on Ovarian cancer diagnosis and treatment (35 papers), Endometrial and Cervical Cancer Treatments (26 papers) and Intraperitoneal and Appendiceal Malignancies (11 papers). R.R. Barakat collaborates with scholars based in United States. R.R. Barakat's co-authors include Nadeem R. Abu‐Rustum, D.S. Chi, John P. Curtin, Douglas A. Levine, Yukio Sonoda, Ennapadam Venkatraman, Martee L. Hensley, Kaled M. Alektiar, Jae Huh and Mario M. Leitão and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

R.R. Barakat

59 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?

2006 465 citations D.S. Chi, Jae Huh et al. Gynecologic Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R.R. Barakat United States	28	2.0k	1.6k	980	425	383	60	2.8k
Timothy O. Wilson United States	22	1.5k 0.8×	1.4k 0.9×	980 1.0×	461 1.1×	350 0.9×	37	2.6k
Gerardo Zanetta Italy	30	2.1k 1.1×	1.5k 0.9×	1.0k 1.1×	497 1.2×	400 1.0×	80	3.1k
Jeffrey D. Bloss United States	19	1.4k 0.7×	1.8k 1.1×	660 0.7×	328 0.8×	699 1.8×	36	2.5k
Edgardo Yordan United States	24	1.5k 0.8×	1.8k 1.1×	964 1.0×	440 1.0×	635 1.7×	51	2.9k
Suk‐Joon Chang South Korea	22	1.6k 0.8×	1.3k 0.8×	1.1k 1.1×	374 0.9×	326 0.9×	135	2.3k
Pierluigi Benedetti Panici Italy	12	1.8k 0.9×	869 0.5×	1.2k 1.2×	480 1.1×	103 0.3×	24	2.2k
Paul B. Heller United States	24	2.5k 1.3×	3.3k 2.1×	742 0.8×	410 1.0×	973 2.5×	56	4.0k
D. Franchi Italy	26	1.7k 0.9×	1.4k 0.8×	594 0.6×	246 0.6×	166 0.4×	90	2.4k
David Atallah Lebanon	23	899 0.5×	744 0.5×	727 0.7×	342 0.8×	148 0.4×	109	1.9k
Gregorio Delgado United States	19	862 0.4×	1.3k 0.8×	665 0.7×	339 0.8×	875 2.3×	47	2.0k

Countries citing papers authored by R.R. Barakat

Since Specialization

Citations

This map shows the geographic impact of R.R. Barakat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.R. Barakat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.R. Barakat more than expected).

Fields of papers citing papers by R.R. Barakat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.R. Barakat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.R. Barakat. The network helps show where R.R. Barakat may publish in the future.

Co-authorship network of co-authors of R.R. Barakat

This figure shows the co-authorship network connecting the top 25 collaborators of R.R. Barakat. A scholar is included among the top collaborators of R.R. Barakat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.R. Barakat. R.R. Barakat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barlin, Joyce N., K. Long, Edward J. Tanner, et al.. (2013). Optimal (≤1cm) but visible residual disease: Is extensive debulking warranted?. Gynecologic Oncology. 130(2). 284–288. 19 indexed citations

Leitão, Mario M., Fady Khoury‐Collado, Ginger J. Gardner, et al.. (2013). Impact of incorporating an algorithm that utilizes sentinel lymph node mapping during minimally invasive procedures on the detection of stage IIIC endometrial cancer. Gynecologic Oncology. 129(1). 38–41. 51 indexed citations

Milgrom, Sarah A., Marisa Kollmeier, Nadeem R. Abu‐Rustum, et al.. (2013). Positive peritoneal cytology is highly predictive of prognosis and relapse patterns in stage III (FIGO 2009) endometrial cancer. Gynecologic Oncology. 130(1). 49–53. 24 indexed citations

Kim, Christine H., Nadeem R. Abu‐Rustum, D.S. Chi, et al.. (2012). Reproductive outcomes of patients undergoing radical trachelectomy for early-stage cervical cancer. Gynecologic Oncology. 125(3). 585–588. 82 indexed citations

Shih, Karin, Eun Young Yun, Ginger J. Gardner, et al.. (2011). Surgical cytoreduction in stage IV endometrioid endometrial carcinoma. Gynecologic Oncology. 122(3). 608–611. 44 indexed citations

Shih, Karin, Karuna Garg, Douglas A. Levine, et al.. (2011). Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40years of age and younger. Gynecologic Oncology. 123(1). 88–94. 46 indexed citations

Khoury‐Collado, Fady, Melissa P. Murray, Yukio Sonoda, et al.. (2011). Sentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodes. Gynecologic Oncology. 122(2). 251–254. 117 indexed citations

Gallagher, David, Jason Konner, K.M. Bell-McGuinn, et al.. (2010). Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity. Annals of Oncology. 22(5). 1127–1132. 91 indexed citations

Shih, Karin, Qin Zhou, Jae Huh, et al.. (2010). Risk factors for recurrence of ovarian borderline tumors. Gynecologic Oncology. 120(3). 480–484. 80 indexed citations

10.

Shih, Karin, D.S. Chi, R.R. Barakat, & Mario M. Leitão. (2010). Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: An updated series. Gynecologic Oncology. 117(2). 330–335. 38 indexed citations

11.

Shih, Karin, D.S. Chi, R.R. Barakat, & Mario M. Leitão. (2009). Beyond tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer. Gynecologic Oncology. 116(3). 364–369. 27 indexed citations

12.

Bochner, Bernard H., Scott R. Gerst, Kaled M. Alektiar, et al.. (2008). Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgery. International Journal of Gynecological Cancer. 18(5). 1139–1144. 27 indexed citations

13.

Einstein, M. Heather, R.R. Barakat, Yukio Sonoda, et al.. (2007). Management of uterine malignancy found incidentally after supracervical hysterectomy or uterine morcellation for presumed benign disease. International Journal of Gynecological Cancer. 18(5). 1065–1070. 133 indexed citations

14.

Sonoda, Yukio, et al.. (2007). Resection of recurrent cervical cancer after total pelvic exenteration. International Journal of Gynecological Cancer. 17(1). 137–140. 9 indexed citations

15.

Levine, Douglas A., Oscar Lin, R.R. Barakat, et al.. (2001). Risk of Endometrial Carcinoma Associated with BRCA Mutation. Gynecologic Oncology. 80(3). 395–398. 106 indexed citations

16.

Harlap, Susan, Sara H. Olson, Alan A. Arslan, et al.. (2001). Epithelial Ovarian Carcinoma and European Birthplace of Grandparents. Gynecologic Oncology. 81(1). 25–32. 6 indexed citations

17.

Abadi, Maria, R.R. Barakat, & Patricia E. Saigo. (2000). Effects of Tamoxifen on Cervicovaginal Smears from Patients with Breast Cancer. Acta Cytologica. 44(2). 141–146. 15 indexed citations

18.

Gemignani, Mary L., et al.. (1999). Laparoscopic-Assisted Vaginal Hysterectomy for Endometrial Cancer: Clinical Outcomes and Hospital Charges. Gynecologic Oncology. 73(1). 5–11. 156 indexed citations

19.

Husain, Amreen, et al.. (1998). Gastrointestinal Toxicity andClostridium DifficileDiarrhea in Patients Treated with Paclitaxel-Containing Chemotherapy Regimens. Gynecologic Oncology. 71(1). 104–107. 60 indexed citations

20.

Hann, Lucy E., et al.. (1997). Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings.. American Journal of Roentgenology. 168(3). 657–661. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact